NBIX vs OSIS · P/E 45, rev $1.77B vs P/E 26, rev $484.1M
Neurocrine Biosciences Inc (NBIX) versus OSI Systems Inc (OSIS) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
OSI Systems Inc (OSIS) is a electronic components company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported OSIS revenue for 2026-06-30 was $484.1M. Net income was $55.2M. Revenue was down 4.1% from 2025-06-30 to 2026-06-30. OSIS currently screens at market cap $3.86B and trailing P/E 25.9.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. OSIS currently screens at market cap $3.86B and trailing P/E 25.9.
Not investment advice. Open the NBIX and OSIS stock pages for the full models.
Not investment advice.